Home > News > After a pause, buckyballs make it to the big time
October 17th, 2003
After a pause, buckyballs make it to the big time
Buckyballs, the soccer ball-shaped molecules that helped kick-start interest in nanoscale science and technology in the 1990s, finally made the big time. The biotech startup C Sixty announced Thursday that it is partnering with the pharmaceutical company Merck & Co. to develop drugs based on buckyballs, formally known as buckminsterfullerenes. If they are successful, fullerenes could find a use that is both medically beneficial and lucrative, and open the door for high-volume production of fullerenes.
Creation of 'Rocker' protein opens way for new smart molecules in medicine, other fields December 18th, 2014
Iranian Researchers Produce Electrical Pieces Usable in Human Body December 18th, 2014
Unraveling the light of fireflies December 17th, 2014
First Home-Made Edible Herbal Nanodrug Presented to Pharmacies across Iran December 17th, 2014